- Telehealth Visits
- Insurance plan information
Jenna Lester, MD
Dermatology- Telehealth Visits
- Insurance plan information
Jenna Lester, MD
Dermatology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Dermatology, American Board of Dermatology
Residency
- Dermatology, University of CA at San Francisco- Dermatology GME
Internship
- Internal Medicine, Beth Israel Deaconess Medical Center GME
Degree
- MD, Warren Alpert Medical School of Brown University
Academic title
- Clinical Professor
My expertise
Specialties
Locations
My work
UCSF opens 'skin of color' dermatology clinic to address disparity in care
My research
Publications
Showing 1-6 of 190 reviews
- June 23, 20265 out of 5 Stars
Dr Lester is one of the best doctors I have ever worked with. I have recommended her to others.
- June 17, 20265 out of 5 Stars
Dr Lester is excellent
- June 11, 20265 out of 5 Stars
Dr. Lester is amazing. She is personable, she listens and gives you all the information. She is knowledgeable about the newest research and informs you of all options. Highly recommend her as a physician.
- June 9, 20265 out of 5 Stars
I was met by the resident (Zaccaria) and lead dermatologist (Lester), I felt seen, heard, respected
- June 8, 20265 out of 5 Stars
She's a terrific and thorough doctor. She spots things I might overlook.
- June 1, 20265 out of 5 Stars
I specifically sought out Dr Lester for her SOC and health equity work. She appears to be careful and respectful especially of patient choice. Open minded and disciplined. I felt safe and relaxed with her engagement.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.